Frederick Arthur Brookfield
65Patents
14h-index
86Co-inventors
83Inventor score
Filing activity: Oct 22, 2004 → Sep 22, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8674132B2 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | Chemistry; Metallurgy | 34 | Active |
| US8227639B2 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | Chemistry; Metallurgy | 34 | Active |
| US8030356B2 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | Emerging Cross-Sectional Technologies | 31 | Active |
| USRE45314E1 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | General | 28 | Active |
| US8106069B2 | Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them | Human Necessities | 25 | Active |
| US8198298B2 | Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors | Human Necessities | 24 | Active |
| US9221780B2 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | Emerging Cross-Sectional Technologies | 22 | Active |
| US8318705B2 | Nitroso compounds as nitroxyl donors and methods of use thereof | Emerging Cross-Sectional Technologies | 21 | Active |
| US9115064B2 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | Chemistry; Metallurgy | 21 | Active |
| US7582672B2 | Compounds for the treatment of CRTH2-mediated diseases and conditions | Chemistry; Metallurgy | 19 | Expired |
| US9156804B2 | Nitroxyl donors with improved therapeutic index | Chemistry; Metallurgy | 18 | Active |
| US8987326B2 | Nitroxyl donors with improved therapeutic index | Chemistry; Metallurgy | 18 | Active |
| US9018411B2 | Bis-acylated hydroxylamine derivatives | Chemistry; Metallurgy | 15 | Active |
| US8791134B2 | Nitroso compounds as nitroxyl donors and methods of use thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US9487498B2 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | Emerging Cross-Sectional Technologies | 14 | Active |
| US9586896B2 | Nitroxyl donors with improved therapeutic index | Chemistry; Metallurgy | 14 | Active |
| US8883785B2 | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | Human Necessities | 12 | Active |
| US9725410B2 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | Emerging Cross-Sectional Technologies | 10 | Active |
| US9968584B2 | Nitroxyl donors with improved therapeutic index | Chemistry; Metallurgy | 9 | Active |
| US9458127B2 | Bis-acylated hydroxylamine derivatives | Chemistry; Metallurgy | 9 | Active |
| US9969684B2 | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors | Emerging Cross-Sectional Technologies | 8 | Active |
| US8314257B2 | Treatment of CRTH2-mediated diseases and conditions | Chemistry; Metallurgy | 6 | Active |
| US8163931B2 | Treatment of CRTH2-mediated diseases and conditions | Chemistry; Metallurgy | 6 | Active |
| US10548872B2 | Pharmaceutical compositions comprising nitroxyl donors | Chemistry; Metallurgy | 6 | Active |
| US7226923B2 | Phthalazinone derivatives | Human Necessities | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.